| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/15/2009 | US7589084 Anticancer compositions, and methods of making and using the same |
| 09/15/2009 | US7589070 Surface modification for improving biocompatibility |
| 09/15/2009 | US7589056 Agent for the prevention and treatment of sexually transmitted diseases-I |
| 09/15/2009 | US7588903 Use of isogenic drug-resistant cell lines to determine the sequence of chemotherapeutic drug treatment |
| 09/15/2009 | US7588787 Medicated production for local use based on natural materials |
| 09/15/2009 | US7588786 Polyoxyl 35 castor oil; medium chain mono- and diglycerides, an essential oil, and a (poorly soluble) drug such as ubiquinone; capsules, solid dosage forms |
| 09/15/2009 | US7588753 Synergistically pro-penetrating solutions for ungual/peri-ungual dermatological/cosmetic applications |
| 09/15/2009 | US7588752 Derived from milk protein casein; for use in dentistry |
| 09/15/2009 | CA2473991C Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
| 09/15/2009 | CA2463583C Highly compressible ethylcellulose for tableting |
| 09/15/2009 | CA2459924C Process for preparing concentrate thickener compositions |
| 09/15/2009 | CA2451233C Stackable low depth tray |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2408417C Local anesthetic methods and kits |
| 09/15/2009 | CA2407754C Prodrugs of hiv replication inhibiting pyrimidines |
| 09/15/2009 | CA2393483C Stable pharmaceutical preparations comprising a benzimidazole and process for their production |
| 09/15/2009 | CA2371462C Modified protein matrices |
| 09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
| 09/15/2009 | CA2366514C Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 09/15/2009 | CA2336952C 5-thia-.omega.-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 09/15/2009 | CA2330330C Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 09/15/2009 | CA2255052C Sustained release preparation of prostaglandin i derivatives |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/11/2009 | WO2009111271A1 Polymer paclitaxel conjugates and methods for treating cancer |
| 09/11/2009 | WO2009111170A1 Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide |
| 09/11/2009 | WO2009110464A1 Composition for improvement in nutrition |
| 09/11/2009 | WO2009110351A1 Transdermally absorbable preparation |
| 09/11/2009 | WO2009110009A2 Opthalmic composition |
| 09/11/2009 | WO2009110004A1 Stable pharmaceutical compositions qf carvedilol |
| 09/11/2009 | WO2009109990A2 Pharmaceutical composition of pramipexole |
| 09/11/2009 | WO2009109861A1 Methods of treatment employing prolonged continuous infusion of belinostat |
| 09/11/2009 | WO2009109741A1 Clopidogrel solution for oral administration |
| 09/11/2009 | WO2009109596A1 Nicorandil carriers with enhanced stability |
| 09/11/2009 | WO2009090624A3 Chitosan gel for dermatological use, production method therefor and use of same |
| 09/11/2009 | WO2009085302A3 Method and multilayered device for controlled topical delivery of therapeutic agents to the skin |
| 09/11/2009 | WO2009077154A8 Hydroxyalkyl starch derivatives and process for their preparation |
| 09/11/2009 | WO2009057000A3 Skin cooling composition |
| 09/11/2009 | WO2009038701A3 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 09/11/2009 | WO2009034136A3 Pharmaceutical compound |
| 09/11/2009 | WO2009030065A8 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 09/11/2009 | WO2008120085A3 Angiogenic composition |
| 09/11/2009 | WO2008112873A3 Binding ligand linked drug delivery conjugates of tubulysins |
| 09/11/2009 | WO2008093195A3 Chitosan-based colloidal particles for rna delivery |
| 09/11/2009 | CA2717825A1 Opthalmic composition |
| 09/11/2009 | CA2717736A1 Modulation of srpx2-mediated angiogenesis |
| 09/11/2009 | CA2717207A1 Methods of treatment employing prolonged continuous infusion of belinostat |
| 09/11/2009 | CA2716977A1 Nicorandil carriers with enhanced stability |
| 09/11/2009 | CA2716130A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 09/11/2009 | CA2714395A1 Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide |
| 09/11/2009 | CA2713989A1 Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens |
| 09/10/2009 | US20090227802 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 09/10/2009 | US20090227770 Polypeptide carrier protein |
| 09/10/2009 | US20090227768 Anti-Allergic Complex Molecules |
| 09/10/2009 | US20090227691 Method for releasing molecule of interest based on target nucleic acid sequence |
| 09/10/2009 | US20090227690 Cyclodextrin Inclusion Complexes and Methods of Preparing Same |
| 09/10/2009 | US20090227689 Low-Swelling Biocompatible Hydrogels |
| 09/10/2009 | US20090227660 GLP-1 gene delivery for the treatment of type 2 diabetes |
| 09/10/2009 | US20090227658 Methods and compositions for immunization against hiv |
| 09/10/2009 | US20090227536 Compositions comprising pectin and ascorbic acid |
| 09/10/2009 | US20090227535 Process for producing natural immunobiotic extract and uses thereof |
| 09/10/2009 | US20090227517 Myostatin binding agents |
| 09/10/2009 | US20090227504 Pegylated Factor VII Glycoforms |
| 09/10/2009 | US20090226977 Mutant Strains of Pseudomonas Fluorescens And Variants Thereof, Methods For Their Production, And Uses Thereof In Alginate Production |
| 09/10/2009 | US20090226942 Modified aerolysin and methods of use for treating lung cancer |
| 09/10/2009 | US20090226520 Medical composition employing nanostructures |
| 09/10/2009 | US20090226511 Novel pharmaceutical formulation in the form of cellulose capsules suitable for benzimidazole derivatives |
| 09/10/2009 | US20090226507 Hydroxide-releasing agents as skin permeation enhancers |
| 09/10/2009 | US20090226491 Water-based delivery systems |
| 09/10/2009 | US20090226484 Immunogenic LHRH compositions and methods relating thereto |
| 09/10/2009 | US20090226468 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS |
| 09/10/2009 | US20090226393 Polymer paclitaxel conjugates and methods for treating cancer |
| 09/10/2009 | US20090226392 Phosphate-Binding Polymers for Oral Administration |
| 09/10/2009 | US20090226385 Method for Enhancing Dispersion of Inorganic Compounds Using Silicone-Containing Esters and Compositions Formed Therefrom |
| 09/10/2009 | DE102008012015A1 Verbesserte Isomalt-haltige Komprimate und Verfahren zu ihrer Herstellung Improved isomalt-containing compressed and processes for their preparation |
| 09/09/2009 | EP2098593A1 hTERT expression regulatory gene |
| 09/09/2009 | EP2098250A1 Orally disintegrating solid preparation |
| 09/09/2009 | EP2098249A1 Nicorandil carriers with enhanced stability |
| 09/09/2009 | EP2098235A1 Method for prevention of discoloration with time of donepezil-containing skin adhesive preparation |
| 09/09/2009 | EP2098234A1 Skin adhesive preparation comprising stabilized donepezil |
| 09/09/2009 | EP2098233A1 Skin adhesive preparation comprising stabilized donepezil |
| 09/09/2009 | EP2098232A1 Percutaneous absorption preparation |
| 09/09/2009 | EP2098230A1 Use of cytoskeletal inhibitors in crystalline form for the inhibition or prevention of restenosis |
| 09/09/2009 | EP2098222A1 Physiologically active substance-containing granular composition and method of producing the same |
| 09/09/2009 | EP2098221A1 Composition for iontophoresis for delivery through hair pore |
| 09/09/2009 | EP2097534A2 Human antibodies that bind cd70 and uses thereof |
| 09/09/2009 | EP2097529A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 09/09/2009 | EP2097457A1 Derivatives of acid polysaccharides |
| 09/09/2009 | EP2097453A2 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 09/09/2009 | EP2097109A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 09/09/2009 | EP2097108A2 Factor ix moiety-polymer conjugates having a releaseable linkage |
| 09/09/2009 | EP2097107A2 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
| 09/09/2009 | EP2097086A2 Contact lens compositions |
| 09/09/2009 | EP2097077A1 Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use |
| 09/09/2009 | EP2097074A2 Topical pharmaceutical composition |
| 09/09/2009 | EP2097073A1 Stable and ready-to-use oil-in-water propofol microemulsion |
| 09/09/2009 | EP2097068A2 Formulations of peg-interferon alpha conjugates |
| 09/09/2009 | EP2097066A2 Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics |
| 09/09/2009 | EP2097065A2 Foamable waterless compositions with modulating agents |
| 09/09/2009 | EP2097063A2 Helically-shaped drug delivery system |